Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: Ypsomed Holding AG

Market Cap 4.59B 5.75B 4.97B 4.29B 8.01B 548B 8.18B 54.48B 21.13B 265B 21.57B 21.11B 922B P/E ratio 2027 *
26.5x
P/E ratio 2028 * 23x
Enterprise value 4.88B 6.12B 5.3B 4.57B 8.53B 583B 8.72B 58.02B 22.5B 282B 22.98B 22.48B 982B EV / Sales 2027 *
6.97x
EV / Sales 2028 * 6.02x
Free-Float
28.2%
Yield 2027 *
1.2%
Yield 2028 * 1.43%
1 day+1.15%
1 week+4.48%
Current month+1.08%
1 month+18.38%
3 months+27.87%
6 months+12.98%
Current year+7.99%
1 week 333.6
Extreme 333.6
358
1 month 289.2
Extreme 289.2
358
Current year 260.5
Extreme 260.5
358
1 year 260.5
Extreme 260.5
441.5
3 years 243.5
Extreme 243.5
441.5
5 years 121.6
Extreme 121.6
441.5
10 years 102.4
Extreme 102.4
441.5
Manager TitleAgeSince
Chief Executive Officer 49 30/06/2014
Director of Finance/CFO 42 31/03/2024
Chief Operating Officer 62 30/09/2015
Director TitleAgeSince
Director/Board Member 64 31/12/2017
Director/Board Member 56 31/12/2018
Chairman 62 28/06/2022
Date Insider Type Main position Quantity % Market Cap.
12-09Buy 98 0.0007%
12-09Buy 105 0.0008%
12-09Buy 96 0.0007%
Change 5-day change 1-year change 3-year change Capi.($)
+1.55%+4.48%-14.75%+35.19% 5.75B
-2.41%+2.22%-33.71%-12.31% 159B
-1.66%+3.50%-8.28%-4.27% 105B
+0.80%+7.04%-0.72%+57.37% 54.39B
+0.41%-2.26%+53.86%+50.22% 53.5B
-1.56%+3.06%-13.95%-40.15% 41.89B
-3.02%+3.81%-10.94%-40.48% 30.17B
+3.18%+8.01% - - 30.45B
-1.50%+4.61%+45.32%-7.41% 23.64B
+1.07%+2.67%-11.62%+4.17% 21.02B
Average -0.35%+4.30%+0.58%+4.70% 52.5B
Weighted average by Cap. -1.06%+5.25%-7.20%+1.24%

Financials

2027 *2028 *
Net sales 701M 879M 761M 656M 1.22B 83.71B 1.25B 8.33B 3.23B 40.54B 3.3B 3.23B 141B 796M 997M 863M 744M 1.39B 95.01B 1.42B 9.45B 3.67B 46.01B 3.74B 3.66B 160B
Net income 179M 224M 194M 167M 312M 21.37B 319M 2.13B 825M 10.35B 842M 824M 35.99B 201M 252M 218M 188M 352M 24.05B 360M 2.39B 928M 11.65B 948M 927M 40.5B
Net Debt 298M 374M 323M 279M 520M 35.6B 532M 3.54B 1.37B 17.24B 1.4B 1.37B 59.95B 206M 258M 224M 193M 360M 24.61B 368M 2.45B 950M 11.92B 970M 949M 41.44B
Logo Ypsomed Holding AG
Ypsomed Holding AG is a Switzerland-based holding company engaged in the manufacture of injection pens for pharmaceutical and biotech companies. The Company develops and manufactures injection systems for custom-made self-administration, and markets pen needles for the treatment of diabetes, growth disorders or infertility, as well as therapeutic areas. The Company operates two business segments: Injection Systems and Diabetes Care. In the Injection Systems segment, the Company's YDS Ypsomed Delivery Systems offer a range of ready-to-use injection systems for pharmaceutical and biotech companies to administer of drugs or to develop and manufacture them in line with customer requirements. The Diabetes Care segment markets products such as pen needles or insulin pump to diabetics, doctors and health insurance providers. The Company operates its production sites in Burgdorf, Solothurn, Grenchen and Tabor, and sales and distribution network across Europe.
Employees
2,025
Date Price Change Volume
10/06/26 354.20 CHF +1.55% 10,391
09/06/26 348.80 CHF -0.80% 9,676
08/06/26 351.60 CHF -1.01% 13,743
05/06/26 355.20 CHF +2.72% 22,813
04/06/26 345.80 CHF +2.01% 8,870
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
348.80CHF
Average target price
387.83CHF
Spread / Average Target
+11.19%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. YPSN Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
BENEFIT NOW